1. Home
  2. GNFT vs LCNB Comparison

GNFT vs LCNB Comparison

Compare GNFT & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • LCNB
  • Stock Information
  • Founded
  • GNFT 1999
  • LCNB 1877
  • Country
  • GNFT France
  • LCNB United States
  • Employees
  • GNFT N/A
  • LCNB N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • LCNB Major Banks
  • Sector
  • GNFT Health Care
  • LCNB Finance
  • Exchange
  • GNFT Nasdaq
  • LCNB Nasdaq
  • Market Cap
  • GNFT 186.3M
  • LCNB 205.5M
  • IPO Year
  • GNFT 2019
  • LCNB N/A
  • Fundamental
  • Price
  • GNFT $4.11
  • LCNB $15.30
  • Analyst Decision
  • GNFT Strong Buy
  • LCNB
  • Analyst Count
  • GNFT 1
  • LCNB 0
  • Target Price
  • GNFT $13.00
  • LCNB N/A
  • AVG Volume (30 Days)
  • GNFT 3.9K
  • LCNB 20.6K
  • Earning Date
  • GNFT 09-18-2025
  • LCNB 07-22-2025
  • Dividend Yield
  • GNFT N/A
  • LCNB 5.79%
  • EPS Growth
  • GNFT N/A
  • LCNB 186.06
  • EPS
  • GNFT 0.03
  • LCNB 1.49
  • Revenue
  • GNFT $73,187,701.00
  • LCNB $86,864,000.00
  • Revenue This Year
  • GNFT $5.15
  • LCNB N/A
  • Revenue Next Year
  • GNFT N/A
  • LCNB $6.72
  • P/E Ratio
  • GNFT $132.29
  • LCNB $10.20
  • Revenue Growth
  • GNFT 105.01
  • LCNB 22.73
  • 52 Week Low
  • GNFT $2.55
  • LCNB $13.34
  • 52 Week High
  • GNFT $6.42
  • LCNB $17.92
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 58.92
  • LCNB 54.46
  • Support Level
  • GNFT $3.71
  • LCNB $14.33
  • Resistance Level
  • GNFT $4.12
  • LCNB $15.69
  • Average True Range (ATR)
  • GNFT 0.15
  • LCNB 0.43
  • MACD
  • GNFT 0.02
  • LCNB 0.05
  • Stochastic Oscillator
  • GNFT 82.95
  • LCNB 68.79

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

Share on Social Networks: